Results 211 to 220 of about 96,578 (258)
Occurrence of Metabolic Disorders in Bilateral Primary Aldosteronism Compared to Unilateral Primary Aldosteronism. [PDF]
Grasselli C+9 more
europepmc +1 more source
Is It Possible to Screen for Primary Aldosteronism Effectively in Primary Care?
ABSTRACT Objective Primary aldosteronism (PA) is the commonest secondary cause of hypertension but case‐detection remains a challenge. Screening is usually performed in secondary care using an aldosterone:renin ratio (ARR) measurement. Here, we describe the outcomes of screening in primary care, in Oxfordshire, UK.
Harsha Anuruddhika Dissanayake+9 more
wiley +1 more source
Impact of exposure to a mixture of organophosphate esters on the adrenal glands of Sprague Dawley rats. [PDF]
Li Z, Hales BF, Robaire B.
europepmc +1 more source
Targeting Regulation of Macrophage to Treat Metabolic Disease: Role of Phytochemicals
One‐third of the world's population is affected by metabolic syndrome. Complicated pathogenesis and limited drugs cause the growing prevalence of metabolic syndrome. Macrophage‐mediated metaflammation is closely associated with the development of metabolic syndrome. The role of phytochemicals targeting macrophages in the treatment of metabolic syndrome
Zeting Ye+6 more
wiley +1 more source
Mineralocorticoid axis activity and cardiac remodeling in patients with ACTH-dependent Cushing's syndrome. [PDF]
Wolf P+13 more
europepmc +1 more source
Why does infantile epileptic spasms syndrome (IESS) occur with a variety of underlying conditions and why does it respond to adrenocorticotrophin hormone (ACTH)/corticosteroids? Our scoping review summarizes five hypotheses from the literature: gene/epigenetic regulation, stress/HPA axis activation, neuroinflammation/immune function, altered neuronal ...
Emily A. Innes+6 more
wiley +1 more source
EGR1 regulates oxidative stress and aldosterone production in adrenal cells and aldosterone-producing adenomas. [PDF]
Pang Y+10 more
europepmc +1 more source
Abstract Aims Diabetes mellitus remains a prevalent condition worldwide and a significant risk factor for atherosclerotic cardiovascular disease. Recent evidence suggests the use of glucose‐lowering therapies with cardiovascular benefit in optimising the cardiometabolic profile of patients with type 2 diabetes mellitus.
Muhammad Usman Shah+6 more
wiley +1 more source